These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12888315)

  • 1. The range of therapeutic efficacy of atypical antipsychotics: a critical evaluation.
    Dimova A
    Med Hypotheses; 2003 Aug; 61(2):259-64. PubMed ID: 12888315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia.
    Nasrallah HA; Churchill CM; Hamdan-Allan GA
    Am J Psychiatry; 1988 Nov; 145(11):1455-6. PubMed ID: 2903686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risks of long-term neuroleptic treatment of schizophrenia: especially depression and akinesia.
    Rifkin A
    Acta Psychiatr Scand Suppl; 1981; 291():129-36. PubMed ID: 6113730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
    Nasrallah HA; Tandon R
    J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacology of atypical antipsychotics: clinical implications.
    Masand PS
    Am J Health Syst Pharm; 2007 Jan; 64(2 Suppl 1):S3-8; quiz S24-5. PubMed ID: 17215475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical use of antipsychotic medications.
    Coyle JT
    Med Clin North Am; 1982 Sep; 66(5):993-1009. PubMed ID: 6127455
    [No Abstract]   [Full Text] [Related]  

  • 13. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia circa 2006.
    Kane JM
    Am J Psychiatry; 2006 Aug; 163(8):1316-8. PubMed ID: 16877639
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of second-generation antipsychotics in the treatment of psychotic disorders.
    Jackson CW
    Am J Health Syst Pharm; 2007 Apr; 64(8):815. PubMed ID: 17420195
    [No Abstract]   [Full Text] [Related]  

  • 17. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.
    Möller HJ
    World J Biol Psychiatry; 2000 Apr; 1(2):75-91. PubMed ID: 12607203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Cuesta MJ
    J Clin Psychopharmacol; 2013 Jun; 33(3):438-40. PubMed ID: 23609391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.